XFOR X4 Pharmaceuticals, Inc. - Common Stock
$4,29
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$2–$5
77% of range
Analystenbewertung
STRONG BUY
11 analysts
Kursziel
$12
+170% upside
P/E (TTM)
-2.3
ROE
-83.2%
Nettogewinnmarge
-1218.5%
XFOR Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.29
Marktkapitalisierung
$390M
P/E (TTM)
-2.3
EPS (TTM)
$-1.87
Umsatz (TTM)
$6M
Dividendenrendite
—
ROE
-83.2%
Verschuldungsgrad
—
52W-Spanne
$2 – $5
XFOR Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$6M
2018-12-31
→
2025-12-31
EPS
$-1.87
2020-12-31
→
2025-12-31
Freier Cashflow
$-86M
2018-12-31
→
2025-12-31
Margen
-1218.5%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
XFOR
Peer-Median
P/E (TTM)
-2.3
—
P/S (TTM) (K/V (TTM))
60.0
289.4
P/B (K/B)
2.1
2.7
Price / FCF (Kurs / FCF)
-4.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
XFOR
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-1336.7%
—
Net Profit Margin (Nettogewinnmarge)
-1218.5%
-1021.1%
ROA
-36.2%
-57.7%
ROE
-83.2%
-69.1%
ROIC
-46.7%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
XFOR
Peer-Median
Current Ratio (Liquiditätsgrad)
10.2
8.2
Quick Ratio
8.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
XFOR
Peer-Median
Revenue YoY (Umsatz YoY)
150.0%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
16.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
XFOR
Peer-Median
XFOR Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
11 Analysten
- Starker Kauf 5 45,5%
- Kauf 5 45,5%
- Halten 1 9,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
5 Analysten · 2026-08-18
Median
$12.00
Mittelwert
$11.60
← Unter allen Zielen
$4.29
Tief
$10.00
Hoch
$13.00
Median-Ziel
$12.00
+179,7%
Mittelwert-Ziel
$11.60
+170,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.77%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.13 | $-0.18 | 0.05% |
| 31. März 2026 | $-0.16 | $-0.20 | 0.04% |
| 31. Dezember 2025 | $-0.22 | $-0.35 | 0.13% |
| 30. September 2025 | $-0.69 | $-0.93 | 0.24% |
| 30. Juni 2025 | $-3.47 | $-4.42 | 0.95% |
| 31. März 2025 | $0.04 | $-4.53 | 4.6% |
| 31. Dezember 2024 | $-6.00 | $-5.36 | -0.65% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | — |
| RCKT | — | — | — | — | — | — |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | — |
| AGEN | $111M | — | 10.4% | -2.7% | 1.0% | — |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | — |
| PALI | $375M | -7.8 | — | — | -25.4% | — |
| GALT | $271M | -8.7 | — | — | 25.0% | — |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Cost of Revenue | $6M | $797.0K | $0 | $0 | · | · | · | · | |
| R&D Expense | $73M | $82M | $72M | $61M | $51M | $42M | $30M | $20M | |
| SG&A Expense | $44M | $62M | $36M | $27M | $25M | $21M | $18M | $9M | |
| Operating Expenses | · | $39M | $108M | $88M | $85M | $63M | $52M | $29M | |
| Operating Income | $-87M | $-36M | $-108M | $-88M | $-85M | $-60M | $-52M | $-29M | |
| Interest Expense | · | · | $6M | $4M | $4M | $3M | $2M | $720.0K | |
| Interest Income | $5M | $6M | $5M | $219.0K | $10.0K | $273.0K | $1M | $236.0K | |
| Other Non-op | $-753.0K | $332.0K | $554.0K | $-4M | $426.0K | $905.0K | $517.0K | $0 | |
| Pretax Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Income Tax | $41.0K | $310.0K | $78.0K | $28.0K | $17.0K | $148.0K | $0 | $0 | |
| Net Income | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| EPS (Basic) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| EPS (Diluted) | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 | $-3.09 | · | · | |
| Shares (Basic) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| Shares (Diluted) | 42,292,818 | 6,702,073 | 5,927,082 | 63,525,845 | 25,748,797 | 20,077,000 | · | · | |
| EBITDA | $-86M | $-36M | $-107M | $-87M | $-85M | $-60M | $-52M | $-46M |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $217M | $56M | $99M | $122M | $82M | $79M | $126M | $8M | |
| Receivables | $573.0K | $1M | $0 | · | · | · | $0 | · | |
| Inventory | · | $3M | $0 | · | · | · | · | · | |
| Prepaid Expense | $4M | $6M | $7M | $6M | $5M | $4M | $1M | $1M | |
| Current Assets | $262M | $112M | $122M | $129M | $88M | $83M | $129M | $9M | |
| PP&E (Net) | $182.0K | $776.0K | $745.0K | $1M | $2M | $1M | $403.0K | $241.0K | |
| PP&E (Gross) | $1M | $3M | $2M | $2M | $2M | $2M | $667.0K | $417.0K | |
| Accum. Depreciation | $1M | $2M | $2M | $1M | $724.0K | $274.0K | $264.0K | $176.0K | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $27M | $27M | $0 | |
| Intangibles | $9M | $10M | $0 | · | · | · | · | · | |
| Other Non-current Assets | $692.0K | $2M | $1M | $1M | $2M | $3M | $2M | $364.0K | |
| Total Assets | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Accounts Payable | $6M | $9M | $9M | $8M | $4M | $3M | $2M | $3M | |
| Accrued Liabilities | $19M | $23M | $13M | $12M | $8M | $8M | $6M | $3M | |
| Current Liabilities | $26M | $33M | $23M | $22M | $14M | $12M | $9M | $8M | |
| Capital Leases | $0 | $1M | $3M | $4M | $5M | $4M | $2M | · | |
| Other Non-current Liabilities | $525.0K | $831.0K | $432.0K | $173.0K | $826.0K | $462.0K | $16.0K | $205.0K | |
| Total Liabilities | $104M | $124M | $96M | $82M | $53M | $50M | $31M | $22M | |
| Long-term Debt | $75M | $75M | $55M | $32M | $32M | $32M | $20M | $10M | |
| Total Debt | · | · | $55M | $34M | $34M | · | $20M | · | |
| Common Stock | $91.0K | $6.0K | $167.0K | $122.0K | $28.0K | $16.0K | $16.0K | $0 | |
| Retained Earnings | $-595M | $-515M | $-478M | $-377M | $-283M | $-194M | $-132M | $-79M | |
| AOCI | $-109.0K | $-122.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $-119.0K | $0 | |
| Stockholders' Equity | $186M | $22M | $51M | $74M | $64M | $73M | $129M | $-77M | |
| Liabilities + Equity | $290M | $146M | $147M | $156M | $117M | $123M | $161M | $10M | |
| Shares Outstanding | 90,906,920 | 5,698,231 | 167,434,595 | 121,667,250 | 28,127,657 | 16,305,731 | 16,128,862 | 351,652 |
Cashflow 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $796.0K | $419.0K | $513.0K | $499.0K | $351.0K | $103.0K | $103.0K | |
| Stock-based Comp | $4M | $8M | $9M | $5M | $6M | $5M | $2M | $759.0K | |
| Amort. of Intangibles | · | $500.0K | $0 | $0 | · | · | · | · | |
| Restructuring | $7M | $861.0K | · | · | · | · | · | $2M | |
| Other Non-cash | $-12M | $-102M | $-4M | $11M | $11M | $-2M | $3M | $-4M | |
| Operating Cash Flow | $-86M | $-131M | $-97M | $-77M | $-71M | $-59M | $-48M | $-25M | |
| CapEx | $0 | $326.0K | $60.0K | $103.0K | $615.0K | $1M | $174.0K | $0 | |
| Investing Cash Flow | $8M | $67M | $-15M | $-103.0K | $-615.0K | $-1M | $27M | $0 | |
| Net Debt Issued | $0 | $0 | $-2M | $-795.0K | $0 | $0 | $-9M | $-5M | |
| Stock Issued | $239M | $0 | $60M | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $2M | $0 | $0 | · | |
| Net Stock Activity | $239M | · | $0 | $0 | $-2M | · | · | · | |
| Financing Cash Flow | $239M | $20M | $89M | $117M | $74M | $12M | $141M | $7M | |
| Net Change in Cash | $161M | $-44M | $-23M | $40M | $2M | $-47M | $120M | $-19M | |
| Taxes Paid | $338.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-86M | $-131M | $-97M | $-77M | $-72M | $-60M | $-48M | $-41M | |
| Levered FCF | · | · | $-102M | $-81M | $-75M | $-63M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1336.7% | -1423.6% | · | · | · | -1995.8% | · | -1311.0% | |
| Net Margin | -1218.5% | -1464.6% | · | · | · | -2071.0% | · | -1229.2% | |
| Pretax Margin | -1217.8% | -1452.5% | · | · | · | -2066.1% | · | -1229.2% | |
| EBITDA Margin | -1317.0% | -1392.5% | · | · | · | -1984.1% | · | -1306.6% | |
| ROA | -36.2% | -25.5% | -66.8% | -68.8% | -73.9% | -43.8% | -61.9% | -73.4% | |
| ROE | -83.2% | -91.6% | -170.5% | -138.1% | -133.3% | -76.5% | -50.7% | 193.4% | |
| ROIC | -46.7% | -165.7% | -101.8% | -81.4% | -86.6% | -82.4% | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 | 7.0 | 13.7 | 6.5 | |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 | 6.6 | 13.4 | 5.7 | |
| Debt / Equity | · | · | 1.1 | 0.5 | 0.5 | · | 0.2 | · | |
| LT Debt / Equity | · | · | 1.1 | 0.4 | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -18.6 | -21.9 | -23.4 | -22.3 | -24.1 | -44.2 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Inventory Turnover | · | 0.6 | · | · | · | · | · | · | |
| Receivables Turnover | 7.9 | 4.8 | · | · | · | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 150.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.7% | · | · | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $3M | $0 | $0 | $0 | $3M | $0 | $0 | |
| Net Income TTM | $-79M | $-37M | $-101M | $-94M | $-89M | $-62M | $-53M | $-33M | |
| Market Cap | $364M | $3.76B | $4.21B | $3.62B | $1.93B | $3.15B | $5.18B | $6.09B | |
| Enterprise Value | · | · | $4.17B | $3.54B | $1.88B | · | $5.07B | · | |
| P/E | -2.1 | -3.9 | -1.5 | -19.6 | -17.2 | -62.4 | · | · | |
| P/S | 55.9 | 1447.8 | · | · | · | 1048.5 | · | · | |
| P/B | 2.0 | 170.0 | 82.5 | 48.9 | 30.0 | 43.2 | 40.1 | 281.7 | |
| P / Tangible Book | 2.3 | · | 124.9 | 63.9 | 41.1 | 68.8 | · | · | |
| P / Cash Flow | -4.2 | -28.8 | -43.7 | -47.0 | -27.3 | -53.5 | -107.7 | -148.8 | |
| P / FCF | -4.2 | -28.7 | -43.6 | -46.9 | -27.0 | -52.3 | -107.3 | -148.7 | |
| EV / EBITDA | · | · | -38.9 | -40.6 | -22.3 | · | -98.3 | · | |
| EV / FCF | · | · | -43.2 | -45.8 | -26.3 | · | -105.1 | · | |
| Earnings Yield | -46.8% | -25.4% | -67.8% | -5.1% | -5.8% | -1.6% | · | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $2M | $900.0K | $2M | $560.0K | $563.0K | · | $0 | $0 | $0 | · | · | · | |
| Cost of Revenue | $2M | $598.0K | $364.0K | $351.0K | $326.0K | $5M | $302.0K | $227.0K | $268.0K | $0 | $0 | $0 | $0 | · | · | · | |
| R&D Expense | $15M | $15M | $19M | $17M | $18M | $19M | $22M | $19M | $21M | $20M | $15M | $19M | $16M | $22M | $19M | $14M | |
| SG&A Expense | $9M | $7M | $7M | $12M | $10M | $15M | $15M | $16M | $13M | $17M | $10M | $8M | $10M | $7M | $7M | $6M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | $37M | · | $27M | $26M | $29M | $26M | $20M | |
| Operating Income | $-16M | $-20M | $-24M | $-28M | $-26M | $-9M | $-36M | $-34M | $71M | $-37M | $-25M | $-27M | $-26M | $-29M | $-26M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Interest Income | $2M | $2M | $2M | $901.0K | $665.0K | $1M | $1M | $2M | $2M | $1M | $1M | $1M | $914.0K | $835.0K | $198.0K | $14.0K | |
| Other Non-op | $-107.0K | $14.0K | $-7.0K | $-304.0K | $-547.0K | $105.0K | $700.0K | $226.0K | $144.0K | $105.0K | $212.0K | $17.0K | $202.0K | $123.0K | $-4M | $-441.0K | |
| Pretax Income | $-16M | $-20M | $-24M | $-30M | $-26M | $316.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| Income Tax | $2.0K | $0 | $0 | $-30.0K | $37.0K | $34.0K | $258.0K | $15.0K | $18.0K | $19.0K | $33.0K | $26.0K | $15.0K | $4.0K | $14.0K | $-13.0K | |
| Net Income | $-16M | $-20M | $-24M | $-30M | $-26M | $282.0K | $-40M | $-37M | $91M | $-52M | $-19M | $-2M | $-56M | $-24M | $-29M | $-22M | |
| EPS (Basic) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.93 | $-5.48 | $13.59 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| EPS (Diluted) | $-0.13 | $-0.16 | $2.25 | $-0.69 | $-3.47 | $0.04 | $-5.91 | $-5.48 | $13.57 | $-7.77 | $-16.57 | $-0.01 | $-0.33 | $-0.16 | $0.06 | $-0.26 | |
| Shares (Basic) | 126,344,020 | 126,288,723 | -15,232,980 | 43,272,773 | 7,412,990 | 6,840,035 | -13,341,171 | 6,695,509 | 6,681,349 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| Shares (Diluted) | 126,344,020 | 126,288,723 | -15,262,029 | 43,272,773 | 7,412,990 | 6,869,084 | -13,353,198 | 6,695,509 | 6,693,376 | 6,666,386 | -505,765,985 | 196,987,827 | 168,737,764 | 145,967,476 | -88,859,155 | 83,211,000 | |
| EBITDA | $-16M | $-20M | · | $-28M | $-26M | $-9M | · | $-34M | $71M | $-37M | · | $-27M | $-26M | $-29M | · | $-20M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $195M | $217M | $217M | $70M | $39M | $40M | $56M | $97M | $147M | $60M | · | $132M | $136M | $93M | $122M | $80M | |
| Receivables | $2M | $1M | $573.0K | $891.0K | $1M | $509.0K | $1M | $0 | $0 | · | $0 | · | · | · | · | · | |
| Prepaid Expense | $3M | $3M | $4M | $5M | $5M | $4M | $6M | $4M | $5M | $6M | · | $6M | $6M | $4M | · | $5M | |
| Current Assets | $219M | $242M | $262M | $133M | $73M | $96M | $112M | $143M | $175M | $87M | · | $148M | $148M | $98M | · | $86M | |
| PP&E (Net) | $111.0K | $146.0K | $182.0K | $218.0K | $254.0K | $487.0K | $776.0K | $820.0K | $808.0K | $742.0K | · | $772.0K | $868.0K | $986.0K | · | $1M | |
| PP&E (Gross) | $1M | $1M | $1M | · | $1M | $3M | $3M | $3M | $3M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | · | $1M | $2M | $2M | $2M | $2M | $2M | · | $2M | $1M | $1M | · | $1M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $17M | |
| Intangibles | $13M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $704.0K | $692.0K | $2M | $2M | $3M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $2M | |
| Total Assets | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Accounts Payable | $4M | $5M | $6M | $5M | $8M | $11M | $9M | $9M | $8M | $9M | · | $8M | $5M | $6M | · | $4M | |
| Accrued Liabilities | $14M | $17M | $19M | $17M | $13M | $13M | $23M | $19M | $20M | $13M | · | $16M | $15M | $12M | · | $9M | |
| Current Liabilities | $19M | $24M | $26M | $24M | $23M | $26M | $33M | $29M | $29M | $24M | · | $25M | $22M | $19M | · | $29M | |
| Capital Leases | · | · | $0 | $95.0K | $815.0K | $1M | $1M | $2M | $2M | $2M | · | $3M | $3M | $3M | · | $4M | |
| Other Non-current Liabilities | $523.0K | $526.0K | $525.0K | $525.0K | $535.0K | $567.0K | $831.0K | $1M | $979.0K | $1M | · | $1M | $1M | $350.0K | · | $312.0K | |
| Total Liabilities | $98M | $102M | $104M | $102M | $101M | $107M | $124M | $119M | $116M | $111M | · | $106M | $106M | $73M | · | $52M | |
| Long-term Debt | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $75M | $55M | · | $55M | $32M | $32M | · | $32M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $15M | |
| Common Stock | $96.0K | $94.0K | $91.0K | $25.0K | $8.0K | $6.0K | $6.0K | $168.0K | $168.0K | $168.0K | · | $165.0K | $164.0K | $122.0K | · | $69.0K | |
| Retained Earnings | $-631M | $-615M | $-595M | $-571M | $-541M | $-515M | $-515M | $-476M | $-439M | $-530M | · | $-459M | $-456M | $-401M | · | $-348M | |
| AOCI | $-123.0K | $-122.0K | $-109.0K | $-118.0K | $-138.0K | $-128.0K | $-122.0K | $-114.0K | $-159.0K | $-155.0K | · | $-119.0K | $-119.0K | $-119.0K | · | $-119.0K | |
| Stockholders' Equity | $155M | $168M | $186M | $62M | $4M | $23M | $22M | $60M | $94M | $1M | $51M | $68M | $68M | $52M | $74M | $62M | |
| Liabilities + Equity | $253M | $270M | $290M | $164M | $105M | $130M | $146M | $178M | $211M | $112M | · | $173M | $173M | $124M | · | $113M | |
| Shares Outstanding | 96,114,534 | 94,319,696 | 90,906,920 | 25,146,411 | 7,959,947 | 5,788,745 | 5,698,231 | 168,511,264 | 168,196,180 | 167,937,781 | · | 164,705,712 | 164,418,011 | 122,207,488 | · | 68,734,553 |
Cashflow 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $997.0K | $223.0K | $223.0K | $223.0K | $355.0K | $476.0K | $273.0K | $267.0K | $194.0K | $62.0K | $62.0K | $104.0K | $126.0K | $127.0K | $124.0K | $124.0K | |
| Stock-based Comp | $3M | $2M | $2M | $760.0K | $748.0K | $519.0K | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Amort. of Intangibles | · | · | · | $200.0K | · | · | · | $200.0K | $100.0K | · | · | · | · | · | · | · | |
| Restructuring | $198.0K | $37.0K | $-196.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-2M | · | · | · | $-14M | · | · | · | $16M | · | · | · | $-4M | · | · | |
| Operating Cash Flow | $-21M | $-20M | $-16M | $-28M | $-30M | $-12M | $-33M | $-34M | $-64M | $-34M | $47M | $-69M | $-48M | $-27M | $-19M | $-19M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $41.0K | $92.0K | $134.0K | $59.0K | $35.0K | $8.0K | $8.0K | $9.0K | $34.0K | $9.0K | |
| Investing Cash Flow | $-1M | $19M | $17M | $-29M | $23M | $-3M | $-9M | $-16M | $97M | $-5M | $-5M | $-5M | $-5M | $-9.0K | $-34.0K | $-9.0K | |
| Stock Issued | · | · | $146M | $87M | · | · | $0 | $-159.0K | · | · | $51M | $2.0K | · | · | · | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $443.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $-443.0K | · | · | |
| Financing Cash Flow | $75.0K | $2.0K | $146M | $87M | $6M | $0 | $135.0K | $0 | $20M | $0 | $97.0K | $21M | $69M | $-2M | $61M | $52M | |
| Net Change in Cash | $-22M | $-365.0K | $147M | $30M | $-1M | $-15M | $-42M | $-50M | $87M | $-39M | $-32M | $-5M | $43M | $-29M | $42M | $32M | |
| Free Cash Flow | · | · | · | · | · | $-12M | · | · | · | $-34M | · | · | · | $-27M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-36M | · | · | · | $-28M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -683.0% | -812.2% | · | -1756.6% | -1504.1% | -1049.2% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| Net Margin | -673.2% | -809.6% | · | -1903.9% | -1476.0% | 31.3% | · | -6552.9% | 16133.8% | · | · | · | · | · | · | · | |
| Pretax Margin | -673.1% | -809.6% | · | -1905.8% | -1473.8% | 35.1% | · | -6550.2% | 16136.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -683.0% | -803.3% | · | -1756.6% | -1504.1% | -996.3% | · | -6160.7% | 12629.3% | · | · | · | · | · | · | · | |
| ROA | -9.0% | -10.1% | · | -17.4% | -16.3% | 0.23% | · | -20.9% | 62.3% | -48.9% | · | -1.3% | · | · | · | -18.5% | |
| ROE | -20.3% | -21.1% | · | -49.2% | -52.3% | 2.4% | · | -57.7% | 145.9% | -204.0% | · | -3.4% | · | · | · | -33.1% | |
| ROIC | -10.5% | -12.0% | · | -44.6% | -661.5% | -36.7% | · | -57.9% | 75.3% | -3600.7% | · | -40.7% | · | · | · | -26.3% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.3 | 10.2 | · | 5.6 | 3.2 | 3.7 | · | 4.9 | 6.1 | 3.7 | · | 5.8 | · | · | · | 3.0 | |
| Quick Ratio | 10.2 | 9.2 | · | 3.0 | 1.8 | 1.6 | · | 3.3 | 5.1 | 2.6 | · | 5.2 | · | · | · | 2.8 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 0.2 | |
| Interest Coverage | · | · | · | · | · | · | · | -14.3 | 32.7 | -19.9 | · | -16.7 | -22.5 | -26.4 | · | -19.8 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.5 | 3.1 | · | 3.5 | 3.0 | 0.5 | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $7M | · | $5M | $4M | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| Net Income TTM | $-92M | $-76M | · | $-92M | $29M | $3M | · | $66.0K | $-19M | $-134M | · | $-104M | $-123M | $-89M | · | $-85M | |
| Market Cap | $449M | $390M | · | $86M | $15M | $41M | · | $3.38B | $2.93B | $7.00B | · | $5.39B | · | · | · | $3.53B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | $5.25B | · | · | · | $3.46B | |
| P/E | -1.0 | -1.0 | · | -0.4 | 0.4 | 19.7 | · | 64.7 | 3.2 | -5.0 | · | -43.0 | -43.1 | -15.0 | · | -21.9 | |
| P/S | 55.0 | 58.1 | · | 18.0 | 4.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 2.3 | · | 1.4 | 3.8 | 1.8 | · | 56.7 | 31.0 | 6759.7 | · | 79.7 | · | · | · | 57.0 | |
| P / Tangible Book | 3.6 | 2.7 | · | 2.5 | · | · | · | 105.4 | 43.9 | · | · | 107.2 | · | · | · | 79.2 | |
| P / Cash Flow | · | -19.9 | · | · | · | -3.3 | · | · | -45.8 | -208.4 | · | -78.3 | · | · | · | · | |
| P / FCF | · | · | · | · | · | -3.3 | · | · | · | -208.1 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | -193.1 | · | · | · | -171.7 | |
| Earnings Yield | -95.3% | -103.6% | · | -280.7% | 245.3% | 5.1% | · | 1.5% | 31.4% | -19.8% | · | -2.3% | -2.3% | -6.7% | · | -4.6% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $6M | $3M | $0 | $0 | $0 |
| Betriebsgewinnmarge % | -1336.7% | -1423.6% | — | — | — |
| Nettoergebnis | $-79M | $-37M | $-101M | $-94M | $-89M |
| Verwässerte EPS | $-1.87 | $-5.59 | $-17.07 | $-1.52 | $-3.99 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | 1.1 | 0.5 | 0.5 |
| Liquiditätsgrad | 10.2 | 3.4 | 5.3 | 5.8 | 6.3 |
| Quick Ratio | 8.4 | 1.7 | 4.3 | 5.5 | 5.8 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-86M | $-131M | $-97M | $-77M | $-72M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 92 Einreicher · $429.4M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 38 (+24 vs. Vorquartal) | 25 (+16 vs. Vorquartal) | 19 (-2 vs. Vorquartal) | 13 (-7 vs. Vorquartal) | +7.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| MORGAN STANLEY | $44.014.736 | 9.424.997 | 10,25% | Aktien |
| FMR LLC | $38.862.138 | 8.321.657 | 9,05% | Aktien |
| Bain Capital Life Sciences Investors, LLC | $37.208.011 | 7.967.454 | 8,66% | Aktien |
| PERCEPTIVE ADVISORS LLC | $37.049.403 | 7.933.491 | 8,63% | Aktien |
| Saturn V Capital Management LP | $32.565.512 | 6.973.343 | 7,58% | Aktien |
| Empery Asset Management, LP | $32.365.860 | 6.930.591 | 7,54% | Aktien |
| Deep Track Capital, LP | $27.453.795 | 5.878.757 | 6,39% | Aktien |
| Kalehua Capital Management LLC | $17.385.663 | 3.722.840 | 4,05% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.353.062 | 3.715.859 | 4,04% | Aktien |
| Rosalind Advisors, Inc. | $15.012.957 | 3.214.766 | 3,50% | Aktien |
| BRAIDWELL LP | $13.649.261 | 2.922.754 | 3,18% | Aktien |
| Blackstone Inc. | $12.524.576 | 2.681.922 | 2,92% | Aktien |
| Trails Edge Capital Partners, LP | $12.008.803 | 2.571.478 | 2,80% | Aktien |
| VANGUARD GROUP INC | $11.639.808 | 2.909.952 | 2,71% | Aktien |
| Nantahala Capital Management, LLC | $11.439.016 | 2.449.468 | 2,66% | Aktien |
| BVF INC/IL | $10.431.575 | 2.233.742 | 2,43% | Aktien |
| Venrock Adviser, LLC | $9.032.962 | 1.934.253 | 2,10% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $8.383.316 | 1.794.568 | 1,95% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $6.517.391 | 1.395.587 | 1,52% | Aktien |
| STATE STREET CORP | $6.052.399 | 1.296.017 | 1,41% | Aktien |
| Woodline Partners LP | $4.675.114 | 1.001.095 | 1,09% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.280.223 | 916.536 | 1,00% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.671.417 | 572.038 | 0,62% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.531.738 | 542.128 | 0,59% | Aktien |
| Verdad Advisers, LP | $1.644.274 | 352.093 | 0,38% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.229.443 | 263.264 | 0,29% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.168.901 | 250.300 | 0,27% | Kaufoption |
| Caption Management, LLC | $1.167.500 | 250.000 | 0,27% | Kaufoption |
| Stonepine Capital Management, LLC | $1.050.699 | 224.989 | 0,24% | Aktien |
| Affinity Asset Advisors, LLC | $677.150 | 145.000 | 0,16% | Aktien |
| Nuveen, LLC | $501.507 | 107.389 | 0,12% | Aktien |
| ALPS ADVISORS INC | $447.040 | 95.726 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $444.022 | 95.081 | 0,10% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $407.607 | 87.282 | 0,09% | Aktien |
| DEUTSCHE BANK AG\ | $368.393 | 78.885 | 0,09% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $349.293 | 74.795 | 0,08% | Aktien |
| Bank of New York Mellon Corp | $327.507 | 70.130 | 0,08% | Aktien |
| WELLS FARGO & COMPANY/MN | $316.215 | 67.712 | 0,07% | Aktien |
| Palumbo Wealth Management LLC | $313.432 | 67.116 | 0,07% | Aktien |
| Squarepoint Ops LLC | $313.254 | 67.078 | 0,07% | Aktien |
| CITIGROUP INC | $305.633 | 65.446 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $224.015 | 47.969 | 0,05% | Aktien |
| BANK OF AMERICA CORP /DE/ | $218.841 | 46.861 | 0,05% | Aktien |
| Point72 Asset Management, L.P. | $191.806 | 41.072 | 0,04% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $173.131 | 37.073 | 0,04% | Aktien |
| Jump Financial, LLC | $159.961 | 34.253 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $154.003 | 32.977 | 0,04% | Aktien |
| Invesco Ltd. | $150.575 | 32.243 | 0,04% | Aktien |
| JPMORGAN CHASE & CO | $141.785 | 33.519 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $111.361 | 23.846 | 0,03% | Aktien |
| AXQ CAPITAL, LP | $106.850 | 22.880 | 0,02% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $103.128 | 22.083 | 0,02% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $90.719 | 19.426 | 0,02% | Aktien |
| STIFEL FINANCIAL CORP | $86.483 | 18.519 | 0,02% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $84.527 | 18.100 | 0,02% | Aktien |
| INTECH INVESTMENT MANAGEMENT LLC | $80.744 | 17.290 | 0,02% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $77.055 | 16.500 | 0,02% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $77.055 | 16.500 | 0,02% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $76.513 | 16.384 | 0,02% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $73.963 | 15.838 | 0,02% | Aktien |
| BARCLAYS PLC | $72.707 | 15.569 | 0,02% | Aktien |
| CAXTON CORP | $72.650 | 15.557 | 0,02% | Aktien |
| WINTON GROUP Ltd | $67.248 | 14.400 | 0,02% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65.614 | 14.050 | 0,02% | Aktien |
| Creative Planning | $64.782 | 13.872 | 0,02% | Aktien |
| BlackRock, Inc. | $64.208 | 13.749 | 0,01% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $60.215 | 14.580 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $59.323 | 12.703 | 0,01% | Aktien |
| PRUDENTIAL FINANCIAL INC | $58.375 | 12.500 | 0,01% | Aktien |
| ProShare Advisors LLC | $49.445 | 10.588 | 0,01% | Aktien |
| Indivisible Partners | $46.850 | 10.000 | 0,01% | Aktien |
| Pettinga Financial Advisors LLC | $46.700 | 10.000 | 0,01% | Aktien |
| Legal & General Group Plc | $36.697 | 7.858 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $36.169 | 7.745 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $34.268 | 7.338 | 0,01% | Aktien |
| ROYAL BANK OF CANADA | $12.000 | 2.559 | 0,00% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $9.966 | 2.914 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $8.215 | 1.759 | 0,00% | Aktien |
| Sterling Capital Management LLC | $7.607 | 1.629 | 0,00% | Aktien |
| CIBC Private Wealth Group LLC | $7.408 | 2.166 | 0,00% | Aktien |
| Russell Investments Group, Ltd. | $3.404 | 729 | 0,00% | Aktien |
| GROUP ONE TRADING LLC | $3.325 | 712 | 0,00% | Aktien |
| Bleichroeder LP | $2.779 | 595 | 0,00% | Aktien |
| Blue Trust, Inc. | $1.326 | 284 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $356 | 76.314 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $310 | 66.379 | 0,00% | Aktien |
| Rockefeller Capital Management L.P. | $154 | 33 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $153 | 38 | 0,00% | Aktien |
| UBS Group AG | $149 | 32 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $140 | 30 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $42 | 9 | 0,00% | Aktien |
| HighMark Wealth Management LLC | $28 | 6 | 0,00% | Aktien |
Unternehmensinsider 27 Insider · 7 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paula Ragan | President and CEO | 17. Juni 2019 A | 237.294 | 0 | 0 | $0 |
| Michael Gray | President, CEO and CFO | 27. November 2018 A | 250.000 | 0 | 0 | $0 |
| David Kirske | Chief Financial Officer | 30. Juni 2026 S | 167.750 | 0 | 1 | $-36.393 |
| Adam S. Mostafa | CFO and Treasurer | 17. Juni 2019 A | 10.564 | 0 | 0 | $0 |
| Lynne E Kelley | Chief Medical Officer | 24. April 2019 A | — | 0 | 0 | $0 |
| Eszter Nagy | Chief Scientific Officer | 7. März 2018 A | — | 0 | 0 | $0 |
| David Mantus | Chief Development Officer | 7. März 2018 A | — | 0 | 0 | $0 |
| Kelly Gold | Direktor | 1. Juli 2026 A | — | 0 | 0 | $0 |
| William Aliski | Direktor | 18. September 2019 A | — | 0 | 0 | $0 |
| Rene Russo | Direktor | 17. Juni 2019 A | — | 0 | 0 | $0 |
| David W J Mcgirr | Direktor | 17. Juni 2019 A | — | 0 | 0 | $0 |
| Murray Stewart | Direktor | 29. März 2019 A | — | 0 | 0 | $0 |
| Gary Bridger | Direktor | 13. März 2019 A | — | 0 | 0 | $0 |
| Michael S Wyzga | Direktor | 13. März 2019 A | — | 0 | 0 | $0 |
| Isaac Blech | Direktor | 13. März 2019 A | — | 0 | 0 | $0 |
| Tillman U. Gerngross | Direktor | 5. Juni 2018 A | 392.821 | 0 | 0 | $0 |
| Claudio Nessi | Direktor | 5. Juni 2018 A | 867.639 | 0 | 0 | $0 |
| Amy Schulman | Direktor | 5. Juni 2018 A | — | 0 | 0 | $0 |
| William D Clark | Direktor | 5. Juni 2018 A | — | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 5. Juni 2018 A | 1.868.966 | 0 | 0 | $0 |
| Terrance McGuire | Direktor | 5. Juni 2018 A | 18.031 | 0 | 0 | $0 |
| Michael Jay Ross | Direktor | 15. November 2017 A | 1.868.961 | 0 | 0 | $0 |
| Anna-Maria & Stephen Kellen Foundation, Inc. | 10%-Eigentümer | 20. November 2017 C | 124.381 | 0 | 0 | $0 |
| Bill & Melinda Gates Foundation | 10%-Eigentümer | 20. November 2017 C | 722.179 | 0 | 0 | $0 |
| John Volpone | — | 12. August 2026 S | 265.305 | 0 | 1 | $-109.117 |
| Adam R Craig | — | 12. August 2026 S | 328.651 | 0 | 1 | $-210.616 |
| Anthony Chris Stevens | — | 7. März 2018 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 10 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 Einreichungen | 29. Oktober 2025 | 6,20% | Änderung | Passive Anlage | SEC |
| Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, Matthew D. Perry | 18. August 2025 | 9,99% | Erste Einreichung | — | SEC |
| Bain Capital Life Sciences Fund, L.P., Bain Capital Life Sciences Fund II, L.P., BCIP Life Sciences Associates, LP, BCLS II Investco, LP, BCLS I Investco, LP | 13. August 2025 | 9,99% | Erste Einreichung | — | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint, Terrance G. McGuire ×2 Einreichungen | 17. Juli 2019 | — | Erste Einreichung | — | SEC |
| 28. Mai 2019 | — | Erste Einreichung | — | SEC | |
| Paula Ragan, Ph.D. ×2 Einreichungen | 26. April 2019 | — | Erste Einreichung | M&A / Verkauf | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP IV LLC ×3 Einreichungen | 19. März 2019 | — | Erste Einreichung | — | SEC |
| X4 Pharmaceuticals, Inc. | 6. Dezember 2018 | — | Erste Einreichung | M&A / Verkauf | SEC |
| SVLSF V, LLC, SV Life Sciences Fund V, L.P., SV Life Sciences Fund V Strategic Partners, L.P., SV Life Sciences Fund V (GP), L.P., SVLSF VI, LLC, SV Life Sciences Fund VI, LP., SV Life Sciences Fund VI Strategic Partners, L.P., SV Life Sciences Fund VI (GP), L.P. | 14. Februar 2018 | — | Erste Einreichung | Passive Anlage | SEC |
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, Peter J. Barris, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Joshua Makower, David M. Mott, Chetan Puttagunta, Jon M. Sakoda, Scott D. Sandell, Peter W. Sonsini, Ravi Viswanathan | 29. November 2017 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 13 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,53% | 25.945 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,08% | 275.116 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,02% | 750.719 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 70.293 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.950.293 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 464.950 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 46.744 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 30.148 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.031.672 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.599.387 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.885 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,00% | 1 NS | 31. Mai 2026 | N-PORT |
| ITWO · ProShares Trust | 0,00% | 1 NS | 31. Mai 2026 | N-PORT |